Genetic Signatures Limited (ASX: GSS) - ETF Exposure
- Current share price for GSS : $0.085
Genetic Signatures Limited (GSS) is an ASX-listed company and is held by a number of exchange traded funds (ETFs). It is engaged in the research and development into identifying and commercialization of molecular diagnostics products to aid in the diagnosis of infectious diseases and the sale of associated products into the diagnostic and research marketplaces.
GSS General Information +
| ASX Code | GSS |
| Website | N/A |
| Industry/Sector | Life Sciences Tools & Services |
| Market Cap ($M) | 19 |
| GSS Share Price | $0.085 |
| Day High | $0.085 |
| Day Low | $0.081 |
| Last Close | $0.085 |
| GSS Share Price Movement | - ( No change ) |
Prices as at 10:00, 26 Oct 2026
+Security prices are delayed by at least 20 minutes and are indicative only.
Already own an Australian ETF? You may already have meaningful exposure to GSS
Genetic Signatures Limited (GSS) is held across 1 ETF spanning strategies that include life sciences tools & services exposure . Its weighting in those funds means performance can have an outsized influence - when GSS moves, funds like IMPQ that hold it can move with it.
For more concentrated exposure, ETFs such as IMPQ (eInvest Better Future (Managed Fund)) allocate about 0.3% to GSS , while the average exposure across all 1 ETF that hold it is around 0.3% .
Top ETF holdings
- eInvest Better Future (Managed Fund) (IMPQ) ~ 0.3%
Last updated: ETF data and holdings as at 25 October 2026
Own GSS directly or through an ETF?
How does holding Genetic Signatures Limited (GSS) shares directly compare to ETFs that include it?
|
GSS Direct
|
IMPQ
ASX |
|
|---|---|---|
| Holdings | 1 company | 42 holdings |
| GSS Weight | 100% | 0.3% |
| Diversification | Single Stock | Broad |
| Annual Cost | Brokerage only | - |
| Approx. Yield | 0% | - |
| Star Ratings | - | Not Rated |
Yields and costs are approximate. ETF yields reflect the fund's dividend distributions, not GSS's direct yield. Annual cost uses each ETF's MER.
GSS Exposure on $10,000 investment
How a $10,000 investment in Genetic Signatures Limited (GSS) one week ago compares with ETFs that hold it.
| Security | Investment type | Current price | 7-day price movement | Dollar change | Value today |
|---|---|---|---|---|---|
| Genetic Signatures Limited (GSS) | Direct share | $0.085 | 6.25% | +$625 | $10,625 |
| eInvest Better Future (Managed Fund) (IMPQ) | - | $3.980 | 0% | $0 | $10,000 |
Assumes $10,000 invested 7 days ago. Figures are based on price movement only and exclude distributions, fees and brokerage.
Genetic Signatures Limited (GSS) ETFs
1 ETF hold Genetic Signatures Limited (GSS).
| ETF | GSS Weight | MER | Yield |
|---|---|---|---|
| eInvest Better Future (Managed Fund) (IMPQ) | 0.3% | - | - |
Genetic Signatures Limited (GSS) Upcoming Dividends & Yields
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|---|---|---|---|---|---|---|
| Final | 0.12¢ | 0% | 27 Aug 1996 | 30 Sep 1996 | - | - | - |
See all dividends from Genetic Signatures Limited (GSS) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
Genetic Signatures Limited (GSS) price-sensitive announcements
GSS - Addendum to Notice of Annual General Meeting
Genetic Signatures Limited announced an addendum to its Notice of Annual General Meeting f
Genetic Signatures Limited (GSS)
23 Oct 2026 | 7:52 PM
23 Oct 2026 | 7:52 PM
GSS - Update on Commercial Terms for the Proposed Merger with MAP
Genetic Signatures Limited announced an in-principle revision to the commercial terms of i
Genetic Signatures Limited (GSS)
21 Oct 2026 | 9:18 AM
21 Oct 2026 | 9:18 AM
GSS - Response to Media Speculation & BCAL letter to GSS
Genetic Signatures Limited (ASX: GSS) issued this ASX announcement in response to media sp
Genetic Signatures Limited (GSS)
16 Oct 2026 | 8:25 PM
16 Oct 2026 | 8:25 PM
GSS - Quarterly Activities/Appendix 4C Cash Flow Report
Genetic Signatures Limited’s Quarterly Activities Report and Appendix 4C for the quarter e
Genetic Signatures Limited (GSS)
8 Oct 2026 | 12:36 PM
8 Oct 2026 | 12:36 PM
Genetic Signatures Limited (GSS) Recent ASX Announcements
GSS Financial Summary
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2026A | -$11.93 | -$5.30 | -6.60% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2025A | -$12.73 | -$5.60 | -48.00% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2024A | -$17.86 | -$10.80 | 13.00% | 0.00 | 0.00 | 0.00% | 0.0% |
GSS Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2024 A | 2025 A | 2026 A | 2024 A | 2025 A | 2026 A | 2024 A | 2025 A | 2026 A | ||
| Genetic Signatures Limited (GSS) | $20M | -0.0658 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
GSS Directors
| Name | Position | Start Date |
|---|---|---|
| Mr Michael Anton Aicher | Executive Director - US Operations, Executive Chairman | 16 May 2014 |
| Dr Jenny Lee Harry | Non-Executive Director | 1 Oct 2024 |
| Ms Anne Nicole Lockwood | Non-Executive Director | 1 Oct 2024 |
Genetic Signatures Limited (GSS) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 16 Dec 2024 | AICHER, Michael | Issued | Direct Shares | 66,666 | $0.750 | $49,999.500 |
| 8 Jul 2024 | CHATONSKY, Stephane | Issued | Indirect Shares | 27,750 | $0.750 | $20,812.500 |
| 8 Jul 2024 | WALDRON, Caroline | Issued | Direct Shares | 3,302 | $0.750 | $2,476.500 |
See all changes in directors' interest & trades for Genetic Signatures Limited (GSS) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
GSS Management
| Name | Position |
|---|---|
| Allison Rossiter | -- |
| Sonya Tissera-Isaacs | Company Secretary |
GSS Substantial Shareholders
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Genetic Signatures Limited (GSS). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 33,647,760 (14.81%) | Perennial Value Management Limited |
| 23,173,644 (10.20%) | Bcal Diagnostics Limited |
| 18,341,646 (8.08%) | FIL Limited and the entities |
| 17,069,045 (7.51%) | Regal Funds Management Pty Ltd |
| 16,988,243 (7.48%) | Mercer Investments Ltd |
GSS Calendar of Events
| Date | Event |
|---|---|
| 24 August 2027 | Report (Annual) |
| 24 August 2027 | Report (Prelim) |
| 25 February 2027 | Report (Interim) |
| 16 November 2026 | AGM |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
